Cargando…
Antibody or Anybody? Considering the Role of MRGPRX2 in Acute Drug-Induced Anaphylaxis and as a Therapeutic Target
Acute anaphylaxis to small molecule drugs is largely considered to be antibody-mediated with immunogloblin E (IgE) and mast cell activation being key. More recently, a role for drug-reactive immunoglobulin G (IgG) with neutrophil activation has also been suggested, at least in reactions to neuromusc...
Autores principales: | Mackay, Graham A., Fernandopulle, Nithya A., Ding, Jie, McComish, Jeremy, Soeding, Paul F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639860/ https://www.ncbi.nlm.nih.gov/pubmed/34867939 http://dx.doi.org/10.3389/fimmu.2021.688930 |
Ejemplares similares
-
The effect of substance P and its common in vivo‐formed metabolites on MRGPRX2 and human mast cell activation
por: Hsin, Lin, et al.
Publicado: (2022) -
MRGPRX2 and Adverse Drug Reactions
por: McNeil, Benjamin D.
Publicado: (2021) -
Overexpression of FcεRI on Bone Marrow Mast Cells, but Not MRGPRX2, in Clonal Mast Cell Disorders With Wasp Venom Anaphylaxis
por: Elst, Jessy, et al.
Publicado: (2022) -
GRK2 inhibitors, paroxetine and CCG258747, attenuate IgE-mediated anaphylaxis but activate mast cells via MRGPRX2 and MRGPRB2
por: Thapaliya, Monica, et al.
Publicado: (2022) -
Biological screening of a unique drug library targeting MRGPRX2
por: Yang, Fan, et al.
Publicado: (2022)